We are sending this communication on behalf of Amgen Inc. to inform you of the assignment of a HCPCS code for BLINCYTO® (blinatumomab) for injection for intravenous use. The Centers for Medicare & Medicaid Services (CMS) assigned a HCPCS code for BLINCYTO® which became effective on January 1, 2016. HCPCS Code BLINCYTO Long Descriptor Effective Date […]
The table below lists the current biosimilar HCPCS Codes, the product(s) that are associated with each code and the corresponding required modifier that is used to identify the product. The table will be updated quarterly when new permanent HCPCS codes and modifiers are available for biosimilar products that appear on the ASP price file. Please […]
As you are aware CMS releases quarterly code changes through the Medicare Learning Network/MLN Matters publications. Attached are the upcoming changes that will be in the July 1st update. HCPCS – Drug/Biological Code Changes – July 2015 Update CMS Manual System – Pub 100-04 Medicare Claims Processing Click Here to go to information that is […]
